“The Asian Advanced Wound Care market is estimated to grow at a CAGR of 3.8% from 2014 to 2019. Japan hold the largest share in the Asian Advanced Wound Care market, and is expected to grow at the CAGR of 3.6% during the forecast period of 2014 to 2019.
In this report, the Asian advanced wound care market has been broadly classified on the basis of application, method, geography and end-users. The application segment is divided into, surgical wounds, ulcers and other wounds, where ulcers are further segmented into diabetic foot ulcers, venous ulcers, pressure ulcers and arterial ulcers. The method segment includes dressings and grafts, where dressings are further categorized into antimicrobial dressings, foam dressings, gauze, hydrocolloids collagen, film dressings, hydrogels, composites, alginate dressings and grafts are further segmented into composite skin grafts and biologic grafts. Biologic grafts include autografts, allografts and xenografts. The countries included in the report are Japan, China, India, Republic of Korea (RoK) and Rest of Asia (RoA). The end-user includes in-pateint facilities and out-patient facilities.
Grafts are the fastest growing segment, estimated to grow at the highest CAGR from 2014 to 2019. Factors such as, rising incidences of chronic wounds due to aging population, increasing incidence of diabetes and lifestyle factors are driving the growth of this market.
The Asian advanced wound care market is a competitive market with a number of market players. As of 2014, the Asian advanced wound care market was majorly dominated by Smith and Nephew, PLC (U.K.), Molyncke Health Care (Sweden), and ConvaTec, Inc. (U.S.).
New product launches and partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the advanced wound care market.
“
